Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2016 Filed Nov 22, 2016 21:27 UTC |
STORM KORNELIS J.Director
|
Exercise / conversionCommon Stock, $1 par value | 4,280 | $30.73 | $131,524.40 |
DisclosureSEC source: 0001228779-16-000005 · edgar.xml · nonDerivative · entry 1 STORM KORNELIS J. · CIK 0001228779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 21:25 UTC |
Felicelli RobertCVP, Business Transformation
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 27 | $46.98 | $1,268.46 |
DisclosureSEC source: 0001645279-16-000038 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,361 Underlying: Common Stock, $1 par value · 27 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 21:15 UTC |
Felicelli RobertCVP, Business Transformation
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 27 | $46.99 | $1,268.73 |
DisclosureSEC source: 0000899243-16-032928 · doc4.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,323 Underlying: Common Stock, $1 par value · 27 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter International Inc.'s Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter International Inc.'s Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| October 21, 2016 Filed Oct 25, 2016 20:14 UTC |
GAVIN JAMES R IIIDirector
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 233 | $48.18 | $11,225.94 |
DisclosureSEC source: 0001220966-16-000011 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,953 Underlying: Common Stock, $1 par value · 233 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative. Read SEC document |
| October 21, 2016 Filed Oct 25, 2016 20:09 UTC |
Chen Thomas FDirector
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 147 | $48.18 | $7,082.46 |
DisclosureSEC source: 0001360147-16-000010 · edgar.xml · derivative · entry 1 Chen Thomas F · CIK 0001360147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,630 Underlying: Common Stock, $1 par value · 147 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative. Read SEC document |
| October 21, 2016 Filed Oct 25, 2016 20:06 UTC |
Felicelli RobertCVP, Business Transformation
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 27 | $48.18 | $1,300.86 |
DisclosureSEC source: 0001645279-16-000037 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,309 Underlying: Common Stock, $1 par value · 27 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| October 07, 2016 Filed Oct 11, 2016 20:14 UTC |
Felicelli RobertCVP, Business Transformation
|
GrantDeferred Comp Plan Baxer Common Stock Fund · Derivative | 26 | $48.45 | $1,259.70 |
DisclosureSEC source: 0001645279-16-000036 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,257 Underlying: Common Stock, $1 par value · 26 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:28 UTC |
HELLMAN PETER SDirector
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 572 | $47.64 | $27,250.08 |
DisclosureSEC source: 0001107468-16-000005 · edgar.xml · derivative · entry 1 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,612 Underlying: Common Stock, $1 par value · 572 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person reallocated investment balances deferred under Non-Employee Director Deferred Compensation Plan ("the Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person reallocated investment balances deferred under Non-Employee Director Deferred Compensation Plan ("the Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 20:09 UTC |
Felicelli RobertCVP, Business Transformation
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 27 | $47.49 | $1,282.23 |
DisclosureSEC source: 0001645279-16-000035 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,320 Underlying: Common Stock, $1 par value · 27 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 20:07 UTC |
Felicelli RobertCVP, Business Transformation
|
GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 28 | $45.09 | $1,262.52 |
DisclosureSEC source: 0001645279-16-000034 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,330 Underlying: Common Stock, $1 par value · 28 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:20 UTC |
Pleau ScottCVP - Operations
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $46.18 | $0.00 |
DisclosureSEC source: 0001678065-16-000002 · edgar.xml · derivative · entry 2 Pleau Scott · CIK 0001678065 · CVP - Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock, $1 par value · 100,000 shares Expires 2026-09-01 F2 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:20 UTC |
Pleau ScottCVP - Operations
|
GrantCommon Stock, $1 par value | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001678065-16-000002 · edgar.xml · nonDerivative · entry 1 Pleau Scott · CIK 0001678065 · CVP - Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: The reporting person received a grant of 20,000 restricted stock units which will vest in three equal installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:18 UTC |
Accogli GiuseppeCVP, Renal
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $46.18 | $0.00 |
DisclosureSEC source: 0001678067-16-000003 · edgar.xml · derivative · entry 2 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock, $1 par value · 25,000 shares Expires 2026-09-01 F2 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:18 UTC |
Accogli GiuseppeCVP, Renal
|
GrantCommon Stock, $1 par value | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001678067-16-000003 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,989 F1 · shares: The reporting person received a grant of 5,000 restricted stock units which will vest on September 3, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.